Capital Group Investment Management Pte. Ltd. Abb Vie Inc. Transaction History

Capital Group Investment Management Pte. Ltd.

$475 Million
Q3 2024

A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 8,110 shares of ABBV stock, worth $1.39 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

8,110

Previous 7,911 2.52%

Holding current value

$1.39 Million

Previous $1.36 Million 18.07%

% of portfolio

0.34%

Previous 0.31%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $32,604 - $39,666	199 Added 2.52%	8,110 $1.6 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $1.44 Million - $1.69 Million	-9,328 Reduced 54.11%	7,911 $1.36 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $5.72 Million - $6.52 Million	-35,803 Reduced 67.5%	17,239 $3.14 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $9.82 Million - $11.1 Million	-71,391 Reduced 57.37%	53,042 $8.22 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1.55 Million - $1.79 Million	-11,591 Reduced 8.52%	124,433 $18.5 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $17.6 Million - $21.9 Million	132,746 Added 4049.6%	136,024 $18.3 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $626,305 - $721,284	-4,331 Reduced 56.92%	3,278 $522,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.05 Million - $1.26 Million	7,609 New	7,609 $0

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.

Account

Capital Group Investment Management Pte. Ltd. Abb Vie Inc. Transaction History